ProMIS Neurosciences

PMNNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$121.781 M

$13.58 -0.37%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$39.7M

Loss-making

Shares outstanding

8,967,693

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#298Cumberland PharmaceuticalsCPIX$122.9M
#299EquilliumEQ$122.4M
#300ProMIS NeurosciencesPMN$121.8M
#301GeneluxGNLX$118.1M
#302Milestone PharmaceuticalsMIST$114.7M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of ProMIS Neurosciences, worth $30.3K. Grants and option exercises are excluded.

Johanne KaplanChief Development Officer$30.3K
2,280 shares at $13.30 on 5 Aug 2026 · filed 7 Aug 2026

What if ProMIS Neurosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,371,432

Per share 248,265× higher

Bitcoin $1.74T

$194,214.39

Per share 14,302× higher

Nvidia $5.52T

$615,070.90

Per share 45,292× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for ProMIS Neurosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.